Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.
Mutayoba BK, Michael Hoelscher, Heinrich N, Joloba ML, Lyamuya E, Kilale AM, Range NS, Ngowi BJ, Ntinginya NE, Mfaume SM, Wilfred A, Doulla B, Lyimo J, Kisonga R, Kingalu A, Kabahita JM, Guido O, Kabugo J, Adam I, Luutu M, Namaganda MM, Namutebi J, Kasule GW, Nakato H, Byabajungu H, Lutaaya P, Musisi K, Oola D, Mboowa G, Pletschette M. Mutayoba BK, et al. Among authors: pletschette m. BMC Genomics. 2022 Aug 5;23(1):561. doi: 10.1186/s12864-022-08791-3. BMC Genomics. 2022. PMID: 35931954 Free PMC article.
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Mutayoba BK, Ershova J, Lyamuya E, Hoelscher M, Heinrich N, Kilale AM, Range NS, Ngowi BJ, Ntinginya NE, Mfaume SM, Nkiligi E, Doulla B, Lyimo J, Kisonga R, Kingalu A, Lema Y, Kondo Z, Pletschette M. Mutayoba BK, et al. Among authors: pletschette m. Trop Med Int Health. 2022 Oct;27(10):891-901. doi: 10.1111/tmi.13814. Epub 2022 Sep 11. Trop Med Int Health. 2022. PMID: 36089572 Free PMC article.
Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania.
Mbelele PM, Utpatel C, Sauli E, Mpolya EA, Mutayoba BK, Barilar I, Dreyer V, Merker M, Sariko ML, Swema BM, Mmbaga BT, Gratz J, Addo KK, Pletschette M, Niemann S, Houpt ER, Mpagama SG, Heysell SK. Mbelele PM, et al. Among authors: pletschette m. JAC Antimicrob Resist. 2022 Apr 21;4(2):dlac042. doi: 10.1093/jacamr/dlac042. eCollection 2022 Apr. JAC Antimicrob Resist. 2022. PMID: 35465240 Free PMC article.
Drug-resistant tuberculosis: time for visionary political leadership.
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. Abubakar I, et al. Among authors: pletschette m. Lancet Infect Dis. 2013 Jun;13(6):529-39. doi: 10.1016/S1473-3099(13)70030-6. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531391 Free article. Review.
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, Squire SB, Pantaleo G, Chakaya J, Casenghi M, Migliori GB, Mwaba P, Zijenah L, Hoelscher M, Cox H, Swaminathan S, Kim PS, Schito M, Harari A, Bates M, Schwank S, O'Grady J, Pletschette M, Ditui L, Atun R, Zumla A. McNerney R, et al. Among authors: pletschette m. J Infect Dis. 2012 May 15;205 Suppl 2:S147-58. doi: 10.1093/infdis/jir860. Epub 2012 Apr 10. J Infect Dis. 2012. PMID: 22496353 Free article. Review.
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.
Lanini S, Ioannidis JPA, Vairo F, Pletschette M, Portella G, Di Bari V, Mammone A, Pisapia R, Merler S, Nguhuni B, Langer M, Di Caro A, Edwards SJL, Petrosillo N, Zumla A, Ippolito G. Lanini S, et al. Among authors: pletschette m. Lancet Infect Dis. 2019 Dec;19(12):e444-e451. doi: 10.1016/S1473-3099(19)30284-1. Epub 2019 Aug 23. Lancet Infect Dis. 2019. PMID: 31451421 Review.
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, McHugh TD, Squire SB, Cox H, Ford N, McNerney R, Marais B, Grobusch M, Lawn SD, Migliori GB, Mwaba P, O'Grady J, Pletschette M, Ramsay A, Chakaya J, Schito M, Swaminathan S, Memish Z, Maeurer M, Atun R. Zumla A, et al. Among authors: pletschette m. J Infect Dis. 2012 May 15;205 Suppl 2:S228-40. doi: 10.1093/infdis/jir858. Epub 2012 Apr 3. J Infect Dis. 2012. PMID: 22476720 Free article.
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.
Pritsch M, Radon K, Bakuli A, Le Gleut R, Olbrich L, Guggenbüehl Noller JM, Saathoff E, Castelletti N, Garí M, Pütz P, Schälte Y, Frahnow T, Wölfel R, Rothe C, Pletschette M, Metaxa D, Forster F, Thiel V, Rieß F, Diefenbach MN, Fröschl G, Bruger J, Winter S, Frese J, Puchinger K, Brand I, Kroidl I, Hasenauer J, Fuchs C, Wieser A, Hoelscher M, On Behalf Of The KoCo Study Group. Pritsch M, et al. Among authors: pletschette m. Int J Environ Res Public Health. 2021 Mar 30;18(7):3572. doi: 10.3390/ijerph18073572. Int J Environ Res Public Health. 2021. PMID: 33808249 Free PMC article.
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.
Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A. Marais BJ, et al. Among authors: pletschette m. Lancet Infect Dis. 2013 May;13(5):436-48. doi: 10.1016/S1473-3099(13)70015-X. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531392 Free article. Review.
44 results